Date Range
Date Range
Date Range
AUTOMATED DYNAMICS CORP.
AUTOMATED DYNAMICS CORP.
330 N Sam Huston Prkway E #236
HUSTON, TX, 77060
US
10000 Visite Italiane Sito Web. 5 Parole Chiave Posizionamento su Google. 5000 Contatti per Lead Generation. 60 Articoli per Article Marketing.
Phase I Study Supports Therapeutic Potential of Polatuzumab Vedotin in non-Hodgkin Lymphoma. PSMA ADC Produces Clinically Relevant Declines in PSA and CTC Counts. Enhancing ADCs to Target Diseased Cells and Deliver Payloads. Seattle Genetics and Bristol-Myers Squibb Evaluate New Combination of Brentuximab Vedotin and Nivolumab. and Bristol-Myers Squibb Company have entered into a clinical trial collaboration to evaluate the investigational c.